AN2 Therapeutics, Inc. (ANTX)
4.60
-0.05
(-1.08%)
USD |
NASDAQ |
May 07, 16:00
4.50
-0.10
(-2.17%)
Pre-Market: 20:00
AN2 Therapeutics Research and Development Expense (Annual) : 24.77M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Relmada Therapeutics, Inc. | 26.88M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 81.40M |
| BioMarin Pharmaceutical, Inc. | 700.97M |